MediciNova Inc.

NASDAQ: MNOV · Real-Time Price · USD
1.33
0.03 (2.31%)
At close: Aug 15, 2025, 3:58 PM
1.33
0.00%
After-hours: Aug 15, 2025, 06:40 PM EDT

MediciNova Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Revenue
n/a n/a -999.77M 226.89K 226.89K 226.89K 1B n/a n/a n/a 4.03B 4.03B 4.03B 4.04B 4.04M 4M
Cost of Revenue
5.18K 10.53K 10.84K 16.55K 70.66K 118.94K 161.37K 209.86K 216.44K 212.43K 170.87K 116.69K 62.14K 12.53K 6.15K 6.15K
Gross Profit
-5.37K -10.72K -999.79M 204.98K 156.23K 107.95K 999.84M -209.86K -216.44K -212.43K 4.03B 4.03B 4.03B 4.04B 4.03M 3.99M
Operating Income
-12.74M -12.68M -11.98M -1.16B -1.16B -1.16B -1.16B -13.39M -14.18M -14.63M -13.5M -13.2M -13.42M -10.22M -11.13M -11.25M
Interest Income
1.61M 1.67M 1.72M 1.71M 1.72M 1.83M 1.83M 1.64M 1.28M 809.67K 418.84K 201.23K 144.3K 143.63K 144.17K 145.22K
Pretax Income
-11.15M -11.04M -10.29M -8.16M -8.41M -8.57M -9.51M -12.44M -13.6M -14.07M -13.15M -13.08M -13.33M -10.13M -11.04M -11.16M
Net Income
-11.16M -11.05M -10.29M -8.16M -8.41M -8.53M -9.47M -12.15M -13.25M -13.74M -12.82M -12.99M -13.31M -10.13M -11.04M -11.16M
Selling & General & Admin
5.49M 5.48M 5.04M 1.36B 1.36B 1.36B 1.36B 5.71M 5.67M 5.48M 4.59M 4.7M 4.96M 5.72M 6.61M 6.55M
Research & Development
7.25M 7.19M 6.93M 799.78M 799.87M 799.57M 799.93M 7.68M 8.51M 9.14M 8.91M 8.54M 8.5M 8.54M 8.56M 8.71M
Other Expenses
n/a -16.04K -18.23K -32.39K -55.6K -502.87K -695.4K -689.72K -696.85K -247.28K -66.77K -71.68K -50.3K -59.5K -55.79K -53.41K
Operating Expenses
12.74M 12.66M 11.98M 2.16B 2.16B 2.16B 2.16B 13.39M 14.18M 14.63M 13.5M 13.24M 13.46M 14.25M 15.16M 15.25M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a 63.18K 63.18K 63.18K 63.18K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
12.74M 12.68M 11.98M 2.16B 2.16B 2.16B 2.16B 13.39M 14.18M 14.63M 13.5M 13.24M 13.46M 14.25M 15.16M 15.25M
Income Tax Expense
5.54K 5.54K -433.22K -1.15B -1.15B -1.15B -1.15B -288.2K -349.14K -326.99K -363.71K -118.43K -91.83K -68.24K -32.69K -32.69K
Shares Outstanding (Basic)
49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.04M 48.99M 48.99M 48.8M
Shares Outstanding (Diluted)
49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.05M 49.04M 48.99M 48.99M 48.8M
EPS (Basic)
-0.23 -0.23 -0.21 -0.17 -0.17 -0.17 -0.19 -0.25 -0.27 -0.28 -0.26 -0.27 -0.27 -0.21 -0.23 -0.24
EPS (Diluted)
-0.23 -0.23 -0.21 -0.17 -0.17 -0.17 -0.19 -0.25 -0.27 -0.28 -0.26 -0.27 -0.27 -0.21 -0.23 -0.24
EBITDA
-12.72M -12.65M -11.96M -9.8M -10.05M -9.88M -10.62M -13.37M -14.16M -14.61M -13.48M -13.18M -13.4M -10.19M -11.1M -11.23M
EBIT
-12.74M -12.68M -11.98M -9.82M -10.07M -9.9M -10.64M -13.39M -14.18M -14.63M -13.5M -13.2M -13.42M -10.22M -11.13M -11.25M
Depreciation & Amortization
20.9K 21.08K 21.39K 21.91K 70.66K 118.94K 161.37K 209.86K 216.44K 212.43K 170.87K 123.85K 69.3K 26.15K 25.63K 23.68K